Federal Supply Schedule 36F79721D0227
Award Date
8/15/21
Last Date to Order
8/14/26
Federal Agency
Veterans Integrated Service Network 12
Awardee
Amivas US LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Amarin Pharma, Inc. as a multiple award against the Pharmaceuticals and Drugs schedule. The contract aims to procure drugs, pharmaceuticals, and hematology related products over a potential value of $4 million through February 2024. The contract provides access to Amarin Corporation P L C's portfolio of products through the Federal...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA). The prime contractor is Amphastar Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical goods. The $58,244,500 multiple award contract has a period of performance through January 14, 2027 and aims to procure a broad range of drug,...
The Department of Veterans Affairs awarded a multiple-award federal supply schedule contract to Amryt Pharmaceuticals Inc. with a potential value of $225,000. The schedule is for pharmaceuticals and hematology-related products under contract number 65 IB. This enables ordering through September 2028. Additionally, the Department of Veterans Affairs National Acquisition Center awarded a single-award blanket purchase agreement to Amryt Pharmaceuticals with a value of up to $1,000,000. The BPA...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs, is a $200,000.00 interim agreement with Amarin Pharma, Inc. to provide drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 IB. The contract has an ultimate completion date of August 30, 2024 and was awarded on March 5, 2024 without any set-aside requirements. The purpose of this multiple-award FSS contract is to...
The U.S. Department of Veterans Affairs (VA) has awarded a $1.7 million Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule to Amneal Pharmaceuticals of New York, LLC, a for-profit limited liability company that manufactures pharmaceutical products. The contract has an ultimate completion date of June 30, 2027 and enables the VA to procure a variety of drugs, pharmaceuticals, and hematology-related products from Amneal through task orders over...
The U.S. Department of Veterans Affairs (VA) has awarded a Federal Supply Schedule (FSS) contract to Axsome Therapeutics Inc. for the procurement of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS. The multiple-award contract has a ceiling value of $28,284,570.80 and a period of performance through February 14, 2028. As a for-profit manufacturer, Axsome Therapeutics will provide the VA's Veterans Integrated Service Network 12 with a variety of pharmaceutical and...
This federal contract is an Indefinite Delivery Vehicle (IDV) awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract is a Federal Supply Schedule (FSS) under Schedule 65 I B, which covers Drugs, Pharmaceuticals, & Hematology Related Products. The prime contractor is Avvisto Therapeutics LLC, a for-profit limited liability company that manufactures goods. The contract has a ceiling value of $25,000.00 and...
The federal contract IDV award is for a Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs (VA) for "65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS." The prime contractor is Kamada Inc., a foreign-owned for-profit organization. The contract has a ceiling value of $750,000.00 and a period of performance from July 1, 2024 to June 30, 2029. The contract was awarded without any set-asides and is a multiple award. As an FSS contract, it...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 IB, which covers Drugs, Pharmaceuticals, and Hematology Related Products. The contract was awarded to HLS Therapeutics Inc., a for-profit manufacturer, on July 1, 2022 by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract has a ceiling value of $13,848,500.00 and a period of performance through June 30, 2027. It is a multiple award...
This federal contract IDV is an interim agreement under the Federal Supply Schedule (FSS) 65 IB for Drugs, Pharmaceuticals, and Hematology Related Products, awarded to Avyxa Pharma, LLC, a for-profit limited liability company and manufacturer of goods. The contract has a total ceiling value of $25,000.00 and a period of performance through May 14, 2025. The contracting agency is the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs. The...